Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.
about
Nek4 status differentially alters sensitivity to distinct microtubule poisonsTaxol suppresses dynamics of individual microtubules in living human tumor cellsMulticentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groupsMolecular cloning and heterologous expression of the C-13 phenylpropanoid side chain-CoA acyltransferase that functions in Taxol biosynthesisAnalgesic effects of a hydro-ethanolic whole plant extract of Synedrella nodiflora (L.) Gaertn in paclitaxel-induced neuropathic pain in ratsIn vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubulesPassive mechanical behavior of human neutrophils: effects of colchicine and paclitaxel.Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the ratClinical trials and progress with paclitaxel in ovarian cancerA Novel Microtubule-Disrupting Agent Induces Endoplasmic Reticular Stress-Mediated Cell Death in Human Hepatocellular Carcinoma Cells.Farnesyl transferase inhibitors cause enhanced mitotic sensitivity to taxol and epothilonesCytotoxic studies of paclitaxel (Taxol) in human tumour cell lines.Inhibiting proliferation and enhancing chemosensitivity to taxanes in osteosarcoma cells by RNA interference-mediated downregulation of stathmin expressionS-phase specificity of cell killing by docetaxel (Taxotere) in synchronised HeLa cells.Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro.Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages.LPS and Taxol activate Lyn kinase autophosphorylation in Lps(n), but not in Lpsd), macrophages.Taxol: an important new drug in the management of epithelial ovarian cancer.Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrationsAdditive and supra-additive cytotoxicity of cisplatin-taxane combinations in ovarian carcinoma cell lines.Self-assembled poly(butadiene)-b-poly(ethylene oxide) polymersomes as paclitaxel carriersInhibition of microtubule dynamics impedes repair of kidney ischemia/reperfusion injury and increases fibrosis.Pharmacokinetics and tissue distribution of intraperitoneal 5-fluorouracil with a novel carrier solution in rats.Herbal Medicine Goshajinkigan Prevents Paclitaxel-Induced Mechanical Allodynia without Impairing Antitumor Activity of Paclitaxel.Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: follow-up of a Southwest Oncology Group and GynecologicAre platinum agents, paclitaxel and irinotecan effective for clear cell carcinoma of the ovary? DNA damage detected with γH2AX induced by anticancer agents.Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy.Induction of paclitaxel resistance by the Kaposi's sarcoma-associated herpesvirus latent protein LANA2.Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest.Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy.Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway.Characterisation of a navelbine-resistant bladder carcinoma cell line cross-resistant to taxoids.Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients.S-1 plus intravenous and intraperitoneal Paclitaxel for gastric cancer with peritoneal metastasis.Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell lines.Degradation kinetics of larotaxel and identification of its degradation products in alkaline condition.3-Aroyl-1,4-diarylpyrroles Inhibit Chronic Myeloid Leukemia Cell Growth through an Interaction with Tubulin.Clinical analysis of chemo-resistance risk factors in endometriosis associated ovarian cancer.
P2860
Q24600436-F6D997C4-30D5-4939-ABFD-037177E4AF45Q24657911-0604A5E9-8C29-47DE-807F-DFD8E40A9430Q24679738-D23C9BEB-7720-44AE-8E96-3558DF5E35C7Q30723939-556B8128-53C8-4103-AC38-C98A3F91F28BQ33837092-E99704D4-8E6D-4308-8565-D8B0EED9B652Q34114078-55F387D5-82F5-4C0E-94C4-7064963377D5Q34168230-5E0BF847-6149-4037-80F1-FFA49415826AQ34211840-BE4EA54C-145E-4BD6-909C-433790AFFC5DQ34510070-574CA548-F433-4A48-9E65-1324181CB515Q35768905-7793CEA3-80BB-4F5E-A286-E82847EB7321Q35858587-1E8193B1-BC93-49EF-8E80-C137A3628D03Q35977537-185FC22D-BDFB-4B93-9C8B-F735F2BAEEADQ35991706-DC8C9CFF-F180-488A-837A-B0A21238E206Q36081044-00FB984B-035F-4513-A903-EAA7BC20F6CFQ36136024-8BBDA24A-37CC-4CB9-909C-C5AF53E303F7Q36362095-0A01ADC7-0F73-4574-8E2F-EDA095F2108FQ36437611-E9BD5345-0C21-4E77-8EEC-1094C72CBB06Q36549221-12022B15-9B07-4CAE-BD46-30AFB33D607AQ36598611-F416472E-51BC-42DE-8636-1E0A54CFFA8AQ36617317-891AE224-A012-40EF-B3A8-C635F624A359Q36852356-068F3F5B-3028-4A52-A1C2-86B842CE99ADQ36980406-87F5ABAD-17E2-4C12-9DF2-BC049FD4D08DQ37245482-DEDED7AA-C666-4472-8A66-54E2858E645BQ37254133-6EA77BA1-2560-45C9-825B-7434A7F79F2FQ37347571-071C8B90-E3C0-4E72-88C5-E7388C551CEBQ39332493-0968D53F-DBFC-4934-999F-1A8D5D5CD918Q39619975-43DB9524-DF39-4B82-B42E-A8FFDFC9B855Q40046426-5BDAB825-A6D0-463A-BF91-CB5FDFC4CD5FQ41064243-D088AD14-34B1-4E8D-AAEC-A46B25A8416AQ41184407-BD5B4215-B268-4488-8679-02D68E2E2639Q41328186-49DA488F-8C58-4100-AA50-0309B4FA514FQ41415335-5230BDAB-E8B7-46CB-8EFC-284E584BFB99Q41965292-DF5468B9-7A00-49C3-B056-A7C6C1BC1D73Q42263964-EB5878F0-49F5-4A51-A645-FF4AC1AC638EQ43202485-51993061-9092-4618-89C5-73E07C056158Q50196146-871CF797-0D6C-4B23-8E5E-40EA12F2CA34Q50437578-6EBBCF2F-ED7A-48F1-8088-1288CAD21DFFQ55111208-95BF8F78-F26C-4C97-B89B-2E1E59E5E470
P2860
Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.
@en
type
label
Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.
@en
prefLabel
Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.
@en
P2093
P1433
P1476
Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol
@en
P2093
Donehower RC
Rowinsky EK
P304
P407
P577
1988-07-01T00:00:00Z